The abstract is read at the publisher; the summary is JClub's.
Biofabrication-based regenerative cell therapy frameworks link fabrication-derived attributes to therapeutic function, delivery compatibility, reproducibility, quality control, and safety for structured living products.
- Why it matters: Cell suspension therapies can have limited survival, retention, and tissue integration, creating a need for product formats with controlled organization and material environments.
- What they did: The authors propose a product-oriented framework that distinguishes biomaterial-free versus biomaterial-based constructs and evaluates hybridization, using cross-format comparisons to judge added manufacturing and translational burdens.
- The result: The framework guides design toward the minimum complexity that still achieves clinically meaningful function with reproducible manufacturing and delivery, supporting quality and regulatory evidence.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.